Stockscreener 앱 받기
0.72%
시간 외 거래:
전일 마감가:
$26.49
열려 있는:
$26.395
하루 거래량:
31.51M
Relative Volume:
0.80
시가총액:
$149.04B
수익:
$59.37B
순이익/손실:
$4.25B
주가수익비율:
35.54
EPS:
0.74
순현금흐름:
$8.23B
1주 성능:
-1.57%
1개월 성능:
-0.49%
6개월 성능:
-12.42%
1년 성능:
-6.57%
1일 변동 폭
$26.22
$26.56
1주일 범위
$25.96
$26.87
52주 변동 폭
$24.48
$31.54
화이자 Stock (PFE) Company Profile
명칭
Pfizer Inc
전화
(212) 733-2323
주소
66 HUDSON BOULEVARD EAST, NEW YORK, NY
PFE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PFE
Pfizer Inc
|
26.30 | 149.04B | 59.37B | 4.25B | 8.23B | 0.74 |
|
LLY
Lilly Eli Co
|
725.72 | 689.73B | 40.86B | 8.37B | -2.28B | 9.25 |
|
NVO
Novo Nordisk Adr
|
78.69 | 349.44B | 39.36B | 13.79B | 9.83B | 3.086 |
|
JNJ
Johnson Johnson
|
147.03 | 344.63B | 87.70B | 14.68B | 19.03B | 6.05 |
|
ABBV
Abbvie Inc
|
171.56 | 303.17B | 55.53B | 5.12B | 15.62B | 2.88 |
|
MRK
Merck Co Inc
|
97.92 | 251.88B | 63.17B | 12.15B | 14.84B | 4.77 |
화이자 Stock (PFE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-10 | 재개 | BofA Securities | Neutral |
| 2024-11-15 | 개시 | Wolfe Research | Underperform |
| 2024-10-25 | 재개 | Citigroup | Neutral |
| 2024-10-17 | 개시 | Bernstein | Mkt Perform |
| 2024-08-07 | 업그레이드 | Daiwa Securities | Neutral → Outperform |
| 2024-03-22 | 다운그레이드 | Argus | Buy → Hold |
| 2024-02-23 | 개시 | Guggenheim | Buy |
| 2024-01-04 | 다운그레이드 | TD Cowen | Outperform → Market Perform |
| 2023-10-20 | 재개 | UBS | Neutral |
| 2023-10-16 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-07-17 | 재확인 | JP Morgan | Neutral |
| 2023-07-14 | 개시 | HSBC Securities | Buy |
| 2023-06-29 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2023-05-11 | 다운그레이드 | Daiwa Securities | Outperform → Neutral |
| 2023-03-06 | 개시 | Jefferies | Hold |
| 2023-02-07 | 업그레이드 | Daiwa Securities | Neutral → Outperform |
| 2023-01-26 | 다운그레이드 | UBS | Buy → Neutral |
| 2023-01-17 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-01-04 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-12-13 | 업그레이드 | Goldman | Neutral → Buy |
| 2022-11-18 | 개시 | Credit Suisse | Outperform |
| 2022-05-23 | 개시 | SVB Leerink | Mkt Perform |
| 2022-04-06 | 재개 | Morgan Stanley | Equal-Weight |
| 2022-01-05 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-01-03 | 재확인 | Bernstein | Mkt Perform |
| 2021-12-20 | 재확인 | Cowen | Outperform |
| 2021-12-17 | 개시 | Goldman | Neutral |
| 2021-12-13 | 업그레이드 | UBS | Neutral → Buy |
| 2021-12-09 | 개시 | Wells Fargo | Overweight |
| 2021-11-19 | 개시 | BMO Capital Markets | Outperform |
| 2021-07-27 | 재개 | Truist | Buy |
| 2021-05-06 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2021-04-07 | 재개 | RBC Capital Mkts | Sector Perform |
| 2021-02-04 | 업그레이드 | DZ Bank | Hold → Buy |
| 2020-12-16 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-11-19 | 재개 | Goldman | Neutral |
| 2020-11-10 | 재개 | Bernstein | Mkt Perform |
| 2020-10-12 | 다운그레이드 | Atlantic Equities | Overweight → Neutral |
| 2020-09-29 | 개시 | Berenberg | Hold |
| 2020-06-16 | 개시 | SVB Leerink | Mkt Perform |
| 2020-02-27 | 개시 | Barclays | Equal Weight |
| 2020-02-27 | 업그레이드 | Standpoint Research | Hold → Buy |
| 2020-02-06 | 개시 | Mizuho | Buy |
| 2020-01-07 | 개시 | RBC Capital Mkts | Outperform |
| 2019-10-17 | 재개 | BofA/Merrill | Neutral |
| 2019-07-30 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-07-30 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-04 | 재개 | Morgan Stanley | Overweight |
| 2019-02-20 | 재개 | Citigroup | Neutral |
| 2019-01-31 | 업그레이드 | Argus | Hold → Buy |
| 2019-01-31 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2019-01-23 | 다운그레이드 | UBS | Buy → Neutral |
| 2018-12-11 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2018-11-01 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
모두보기
화이자 주식(PFE)의 최신 뉴스
Cell and Gene Therapy Market Set to Witness Significant Growth by 2025-2032: Pfizer, Inc., Sanofi S.A., Amgen, - EIN News
Is Pfizer Inc. (PFE) the Undervalued Defensive Stock for 2025? - Insider Monkey
Pain Management Therapeutics Market Is Expected To Reach Revenue Of USD 120.7 Bn By 2033, At 3.9% CAGR: Dimension Market Research. - GlobeNewswire Inc.
Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock - Yahoo Finance
Baugh & Associates LLC Acquires 29,025 Shares of Pfizer Inc. (NYSE:PFE) - MarketBeat
M.E. Allison & CO. Inc. Buys New Shares in Pfizer Inc. (NYSE:PFE) - MarketBeat
Public companies who have a significant stake must be disappointed along with institutions after Pfizer Limited's (NSE:PFIZER) market cap dropped by ₹14b - Simply Wall St
Brady Martz Wealth Solutions LLC Invests $1.52 Million in Pfizer Inc. (NYSE:PFE) - MarketBeat
Pfizer (NYSE:PFE) Is Paying Out A Larger Dividend Than Last Year - Yahoo Finance
Pfizer Inc. (NYSE:PFE) Shares Acquired by Steigerwald Gordon & Koch Inc. - MarketBeat
Perkins Coie Trust Co Reduces Stock Position in Pfizer Inc. (NYSE:PFE) - MarketBeat
Liberty One Investment Management LLC Increases Holdings in Pfizer Inc. (NYSE:PFE) - MarketBeat
Nexus Investment Management ULC Has $21.71 Million Stock Holdings in Pfizer Inc. (NYSE:PFE) - MarketBeat
Pfizer (NYSE:PFE) Stock Price Down 0.6%Here's What Happened - MarketBeat
Pfizer Inc. (NYSE:PFE) Shares Sold by Brooklyn Investment Group - MarketBeat
Carnegie Investment Counsel Trims Stock Holdings in Pfizer Inc. (NYSE:PFE) - MarketBeat
Why Pfizer (PFE) Is One of the Best Cheap Stocks to Buy for 2025? - Insider Monkey
Trust Co. of Vermont Has $8.58 Million Stock Holdings in Pfizer Inc. (NYSE:PFE) - MarketBeat
Verity & Verity LLC Sells 58,323 Shares of Pfizer Inc. (NYSE:PFE) - MarketBeat
Integrated Investment Consultants LLC Increases Stock Position in Pfizer Inc. (NYSE:PFE) - MarketBeat
Arkadios Wealth Advisors Has $4.33 Million Stock Holdings in Pfizer Inc. (NYSE:PFE) - MarketBeat
Pfizer Inc. (NYSE:PFE) Shares Sold by FARMERS & MERCHANTS TRUST Co OF LONG BEACH - MarketBeat
Whitener Capital Management Inc. Boosts Stock Holdings in Pfizer Inc. (NYSE:PFE) - MarketBeat
O Keefe Stevens Advisory Inc. Has $2.54 Million Stock Holdings in Pfizer Inc. (NYSE:PFE) - MarketBeat
Baker Chad R Lowers Holdings in Pfizer Inc. (NYSE:PFE) - MarketBeat
Somerset Trust Co Has $571,000 Stake in Pfizer Inc. (NYSE:PFE) - MarketBeat
Pfizer Inc. (NYSE:PFE) Shares Sold by Wedge Capital Management L L P NC - MarketBeat
Pfizer Inc. (NYSE:PFE) Shares Purchased by Empirical Asset Management LLC - MarketBeat
Pfizer Inc. (NYSE:PFE) Shares Purchased by Park Avenue Securities LLC - MarketBeat
Pfizer (NYSE:PFE) Trading Down 0.3%Here's What Happened - MarketBeat
Pfizer Reduces Stake in Haleon through Share Sale - TipRanks
Pfizer Inc - Reuters.com
Avanza Fonder AB Takes Position in Pfizer Inc. (NYSE:PFE) - MarketBeat
Job Details Page - Pfizer
Woodstock Corp Lowers Stock Position in Pfizer Inc. (NYSE:PFE) - MarketBeat
RDA Financial Network Increases Stock Position in Pfizer Inc. (NYSE:PFE) - MarketBeat
Drug Discovery Market Generated Opportunities, Future Scope by 2031 | Pfizer Inc., GlaxoSmithKline LLC, Merck - EIN News
In conversation at Veeva Summit: Jonathan Crowther, Pfizer - pharmaphorum
JPMorgan says Pfizer needs further pipeline progress to change current narrative - Yahoo Finance
Eagle Rock Investment Company LLC Reduces Position in Pfizer Inc. (NYSE:PFE) - MarketBeat
Certified Advisory Corp Has $1.89 Million Stake in Pfizer Inc. (NYSE:PFE) - MarketBeat
Years-Old List of Alleged Pfizer COVID-19 Vaccine 'Side Effects' Is Misleading - Snopes.com
JGP Wealth Management LLC Has $933,000 Stock Position in Pfizer Inc. (NYSE:PFE) - MarketBeat
Tallon Kerry Patrick Purchases Shares of 19,114 Pfizer Inc. (NYSE:PFE) - MarketBeat
Spinal Cord Injury Therapeutics Market Set to Witness Significant Growth by 2025-2032: ReNetX Bio, Inc, Pfizer - EIN News
Pfizer (NYSE:PFE) Trading Down 0.5%What's Next? - MarketBeat
Pfizer CEO At JPM Issues Clear Warning to Kennedy on Vaccines - MedCity News
Pfizer (NYSE:PFE) Shares Down 0.1%What's Next? - MarketBeat
Covid Cases Are Spiking. Is Pfizer Stock Now A Buy? - Investor's Business Daily
Beech Hill Advisors Inc. Sells 26,454 Shares of Pfizer Inc. (NYSE:PFE) - MarketBeat
Pfizer Sells $700M Stake in Haleon, Trimming Ownership to 7.3% - Yahoo Finance
화이자 (PFE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.99%
0.34%
자본화:
|
볼륨(24시간):